Annual EBIT
-$75.30 M
-$256.80 M-141.48%
31 December 2023
Summary:
Fulgent Genetics annual earnings before interest & taxes is currently -$75.30 million, with the most recent change of -$256.80 million (-141.48%) on 31 December 2023. During the last 3 years, it has fallen by -$365.45 million (-125.95%). FLGT annual EBIT is now -111.14% below its all-time high of $686.96 million.FLGT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$18.52 M
+$388.00 K+2.05%
30 September 2024
Summary:
Fulgent Genetics quarterly earnings before interest & taxes is currently -$18.52 million, with the most recent change of +$388.00 thousand (+2.05%) on 30 September 2024. Over the past year, it has dropped by -$25.45 million (-367.22%). FLGT quarterly EBIT is now -106.94% below its all-time high of $266.92 million, reached on 31 March 2021.FLGT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$106.25 M
-$25.45 M-31.49%
30 September 2024
Summary:
Fulgent Genetics TTM earnings before interest & taxes is currently -$106.25 million, with the most recent change of -$25.45 million (-31.49%) on 30 September 2024. Over the past year, it has dropped by -$31.98 million (-43.06%). FLGT TTM EBIT is now -114.15% below its all-time high of $751.00 million, reached on 30 September 2021.FLGT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -141.5% | -367.2% | -43.1% |
| 3 y3 years | -126.0% | -111.6% | -114.2% |
| 5 y5 years | -1385.1% | -1327.2% | -10000.0% |
FLGT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -111.1% | at low | -109.2% | +60.6% | -114.2% | at low |
| 5 y | 5 years | -111.1% | at low | -106.9% | +60.6% | -114.2% | at low |
| alltime | all time | -111.1% | at low | -106.9% | +60.6% | -114.2% | at low |
Fulgent Genetics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.52 M(-2.1%) | -$106.25 M(+31.5%) |
| June 2024 | - | -$18.91 M(-13.3%) | -$80.81 M(-1.1%) |
| Mar 2024 | - | -$21.80 M(-53.7%) | -$81.70 M(-3.6%) |
| Dec 2023 | -$75.30 M(-141.5%) | -$47.03 M(-778.7%) | -$84.72 M(+14.1%) |
| Sept 2023 | - | $6.93 M(-135.0%) | -$74.27 M(-8.0%) |
| June 2023 | - | -$19.80 M(-20.2%) | -$80.74 M(+78.4%) |
| Mar 2023 | - | -$24.82 M(-32.1%) | -$45.26 M(-124.9%) |
| Dec 2022 | $181.50 M(-73.1%) | -$36.58 M(-8103.9%) | $181.50 M(-50.8%) |
| Sept 2022 | - | $457.00 K(-97.1%) | $368.94 M(-30.1%) |
| June 2022 | - | $15.69 M(-92.2%) | $527.76 M(-13.6%) |
| Mar 2022 | - | $201.93 M(+33.9%) | $610.96 M(-9.6%) |
| Dec 2021 | $675.95 M(+133.0%) | $150.86 M(-5.3%) | $675.95 M(-10.0%) |
| Sept 2021 | - | $159.27 M(+61.0%) | $751.00 M(+14.6%) |
| June 2021 | - | $98.90 M(-62.9%) | $655.25 M(+17.2%) |
| Mar 2021 | - | $266.92 M(+18.2%) | $558.99 M(+92.7%) |
| Dec 2020 | $290.16 M(<-9900.0%) | $225.91 M(+255.6%) | $290.16 M(+354.5%) |
| Sept 2020 | - | $63.52 M(+2306.2%) | $63.84 M(+3396.2%) |
| June 2020 | - | $2.64 M(-237.9%) | $1.83 M(-451.8%) |
| Mar 2020 | - | -$1.91 M(+368.0%) | -$519.00 K(+21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$428.00 K(-91.6%) | -$409.00 K(-127.1%) | -$428.00 K(-59.2%) |
| Sept 2019 | - | $1.51 M(+411.5%) | -$1.05 M(-69.2%) |
| June 2019 | - | $295.00 K(-116.2%) | -$3.40 M(-27.6%) |
| Mar 2019 | - | -$1.82 M(+77.2%) | -$4.70 M(-7.3%) |
| Dec 2018 | -$5.07 M(+45.6%) | -$1.03 M(+21.6%) | -$5.07 M(-17.0%) |
| Sept 2018 | - | -$846.00 K(-15.5%) | -$6.11 M(-9.4%) |
| June 2018 | - | -$1.00 M(-54.4%) | -$6.75 M(+14.4%) |
| Mar 2018 | - | -$2.19 M(+6.0%) | -$5.89 M(+69.3%) |
| Dec 2017 | -$3.48 M(-479.3%) | -$2.07 M(+39.8%) | -$3.48 M(+2161.0%) |
| Sept 2017 | - | -$1.48 M(+887.3%) | -$154.00 K(-124.4%) |
| June 2017 | - | -$150.00 K(-168.5%) | $632.00 K(-63.9%) |
| Mar 2017 | - | $219.00 K(-82.6%) | $1.75 M(+90.8%) |
| Dec 2016 | $918.00 K(-118.3%) | $1.26 M(-281.0%) | $918.00 K(-111.9%) |
| Sept 2016 | - | -$695.00 K(-171.6%) | -$7.68 M(+32.3%) |
| June 2016 | - | $970.00 K(-257.7%) | -$5.81 M(-14.3%) |
| Mar 2016 | - | -$615.00 K(-91.6%) | -$6.78 M(+10.0%) |
| Dec 2015 | -$5.01 M(+406.3%) | -$7.34 M(-722.4%) | -$6.16 M(-622.4%) |
| Sept 2015 | - | $1.18 M | $1.18 M |
| Dec 2014 | -$990.00 K | - | - |
FAQ
- What is Fulgent Genetics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Fulgent Genetics?
- What is Fulgent Genetics annual EBIT year-on-year change?
- What is Fulgent Genetics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Fulgent Genetics?
- What is Fulgent Genetics quarterly EBIT year-on-year change?
- What is Fulgent Genetics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Fulgent Genetics?
- What is Fulgent Genetics TTM EBIT year-on-year change?
What is Fulgent Genetics annual earnings before interest & taxes?
The current annual EBIT of FLGT is -$75.30 M
What is the all time high annual EBIT for Fulgent Genetics?
Fulgent Genetics all-time high annual earnings before interest & taxes is $686.96 M
What is Fulgent Genetics annual EBIT year-on-year change?
Over the past year, FLGT annual earnings before interest & taxes has changed by -$256.80 M (-141.48%)
What is Fulgent Genetics quarterly earnings before interest & taxes?
The current quarterly EBIT of FLGT is -$18.52 M
What is the all time high quarterly EBIT for Fulgent Genetics?
Fulgent Genetics all-time high quarterly earnings before interest & taxes is $266.92 M
What is Fulgent Genetics quarterly EBIT year-on-year change?
Over the past year, FLGT quarterly earnings before interest & taxes has changed by -$25.45 M (-367.22%)
What is Fulgent Genetics TTM earnings before interest & taxes?
The current TTM EBIT of FLGT is -$106.25 M
What is the all time high TTM EBIT for Fulgent Genetics?
Fulgent Genetics all-time high TTM earnings before interest & taxes is $751.00 M
What is Fulgent Genetics TTM EBIT year-on-year change?
Over the past year, FLGT TTM earnings before interest & taxes has changed by -$31.98 M (-43.06%)